|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
In low concentrations, inhaled nitric oxide (NO) increases arterial oxygenation in patients with severe
acute respiratory distress syndrome. When present in the ambient atmosphere, NO and its oxidative
derivate, nitrogen dioxide (NO2), are considered pollutants. The aim of this study was to assess
whether the administration of inhaled NO to mechanically ventilated patients was associated with an
increased risk of exposure to NO and NO2 for medical and paramedical staff. During a 1-yr period, indoor and outdoor NO and NO2 concentrations were measured using chemiluminescence in a 14-bed
intensive care unit (ICU) to assess the possible influence of therapeutic NO administration on indoor
pollution. Ambient concentrations of NO within the ICU were 237 ± 147 parts per billion (ppb) during periods of NO administration and 289 ± 147 ppb during periods without NO administration
(mean ± SD, NS). Indoor concentrations of NO and NO2 were entirely dependent on outdoor concentrations and were mainly influenced by climatic conditions such as atmospheric pressure, mass of
clouds, and speed of the wind. Therapeutic administration of concentrations of inhaled NO
5 ppm
to critically ill patients did not affect the ambient concentration of NO and NO2 within the ICU, which
was mainly dependent on the outdoor air pollution. As a consequence, scavenging of exhaust NO
from the breathing circuit in the ventilator does not appear mandatory in ICUs located in areas with
significant urban pollution when NO concentrations
5 ppm are administered.
| |
INTRODUCTION |
|---|
|
|
|---|
Nitric oxide (NO) and nitrogen dioxide (NO2) produced by automobiles and industrial combustion are air pollutants found in the ambient atmosphere of large industrial cities (1). Epidemiological studies have suggested that air pollution caused by oxides of nitrogen and ozone is associated with impaired respiratory function and exacerbation of previous respiratory disease. Although largely influenced by outdoor pollution, indoor concentrations of NO and NO2 also depend on specific domestic sources such as gas stoves and kerosene-fueled space heaters (2). Recently, NO administered by the inhalation route has been shown to improve arterial oxygenation in critically ill patients with acute respiratory distress syndrome (3). In most countries of the European Economic Community, inhaled NO is currently administered in medical and surgical intensive care units (ICUs) and could be an additional source of contamination of the indoor environment. Because of the potential risk of toxicity for medical and paramedical staff working in ICUs, it has been recommended to scavenge exhaust gases coming out from the ventilators of critically ill patients receiving inhaled NO (10). The aim of this study, performed in a Parisian surgical ICU, was to assess whether the therapeutic use of inhaled NO represents a significant source of contamination of the indoor environment in which medical and paramedical staff are working.
| |
METHODS |
|---|
|
|
|---|
From October 1, 1994 to September 30, 1995, indoor and outdoor concentrations of NO and NO2 were regularly measured in the ambient atmosphere of the surgical ICU of la Pitié-Salpétrière Hospital in Paris, France. La Pitié-Salpétrière Hospital is a 2,500-bed teaching hospital (University of Paris VI) located in the southeastern part of the city. The surgical ICU is a 14-bed unit with single rooms and open doors. There is no air conditioning in the unit. The ventilation system consists of an air circulator interconnecting the different rooms, with an air intake located inside the internal courtyard of the hospital. The rudimentary system was built in the early 1970s and is supposed to renew the ambient atmosphere of a given room twice an hour. Among the 159 patients admitted during the study period, 103 were mechanically ventilated for more than 3 d (65%) and 72 (45%) fulfilled the criteria for acute respiratory failure (ARF) (11).
NO was released from a tank of nitrogen that had a NO concentration of 900 ppm and a NO2 concentration < 10 ppm measured using chemiluminescence (Air Liquide, Antony, France). NO was delivered into the inspiratory limb of the ventilator via an electromagnetic flowmeter at continuous flows ranging between 50 and 120 ml/min. Ventilators were free of any scavenging system. A positive response to inhaled NO was defined as an increase in PaO2 of at least 40 mm Hg using an inspired oxygen fraction (FIO2) of 1, and NO was continued until a PaO2 of 70 mm Hg could be obtained without NO at an FIO2 of 0.5. Among the 72 patients with ARF admitted during the study period, 42 were NO responders and received inhaled NO at a mean inspiratory concentration of 4.3 ± 0.7 ppm during a mean period of 7 ± 6 d (range 12 h-34 d). The concentrations of inhaled NO used during the study period were based on three recent studies that demonstrated that the optimal therapeutic concentrations of NO administered to patients with ARF are most often less than 5 ppm (5, 12, 13). In 19 patients, inhaled NO was combined with intravenous almitrine in order to amplify the improvement in arterial oxygenation (13, 14).
During the study period, 100 simultaneous measurements of indoor and outdoor concentrations of NO and NO2 were performed on 100 different days. Indoor concentrations were measured in the main corridor of the ICU, whereas outdoor concentrations were measured by passing a 1-m long tubing through the windows of the ICU that open onto an inside square of the hospital, located 250 m away from Boulevard de l'Hôpital, one of the main streets of Paris characterized by dense and continuous automobile traffic. In periods during which inhaled NO was administered to one or several patients, NO concentrations measured at the bedside of a patient receiving NO were compared with NO concentrations measured at the opposite end of the main corridor of the ICU. Nineteen of these comparative measurements were performed during the study period. On three different occasions, NO2 and NO concentrations were measured outside the ICU in the ambient atmosphere of the circular highway of Paris at 6:00 P.M., the rush hour. Measurements were performed on February 8, July 5, and July 20, 1995, with the 2 d in July being considered as "red days" for pollution in Paris. Using the chemiluminescence apparatus plugged into a power generating set, measurements were performed on the sidewalks of the bridge, La Porte Dorée, in presence of backed-up traffic.
Indoor and outdoor concentrations of NO and NO2 were measured using the same chemiluminescence apparatus used for monitoring NO and NO2 concentrations in the tracheobronchial tree of patients receiving inhaled NO (NOX 4000, Sérès, Aix-en-Provence, France). Calibrations were performed twice a week using a reference NO reservoir tank of 100 ppb (Air Liquide).
At the end of the study period, atmospheric pressure (in mbar), cloud mass (in % of the sky), and wind speed (in mph), corresponding to the place where comparative measurements of indoor and outdoor concentrations of NO and NO2 were performed, were obtained from the meterological service of Paris (Airparif, city of Paris, France).
All data are presented as mean ± SD. Unpaired t test was used to evaluate: (1) differences in indoor NO concentrations measured over periods of time with and without NO administration in the ICU; (2) differences in outdoor NO concentrations according to cloud mass (> or < 40% of the sky); and (3) differences in outdoor NO2 concentrations according to high (> 1,020 mbar) or low to normal atmospheric pressure (< 1,020 mbar). A one-way analysis of variance was used to evaluate differences in outdoor NO concentrations according to three different speeds of wind (< 5 mph, 5-15 mph, and > 15 mph). Linear regression analysis was used to compare indoor concentrations of NO2 and NO, and indoor and outdoor concentrations of NO. Relationships between outdoor concentrations of NO and atmospheric pressure were analyzed using a curve fitter program (Slide Write Plus version 6.0, Carlsbad, NM). Factors influencing indoor NO and NO2 concentrations were determined using a stepwise logistic regression analysis. For indoor NO concentrations, the following factors were analyzed: (1) administration of inhaled NO to one or several patients; (2) outdoor NO concentration; and (3) atmospheric pressure. For indoor NO2 concentrations, the following factors were analyzed: (1) administration of inhaled NO to one or several patients; (2) outdoor NO2 and NO concentrations; and (3) atmospheric pressure.
| |
RESULTS |
|---|
|
|
|---|
The stepwise logistic regression analysis identified increased outdoor NO concentrations as an independent factor associated with an increase in indoor NO concentrations. As shown in Figure 1, administration of inhaled NO to critically ill patients did not affect ambient concentrations of NO within the ICU: 247 ± 137 ppb during periods of NO administration versus 289 ± 147 ppb during periods without NO administration. During periods of NO administration, no statistically significant difference could be found between NO concentrations measured within the ambient atmosphere of the room where NO was administered and NO concentrations measured within the ambient atmosphere of the main corridor of the ICU at a distance of 20 m away from the site of NO administration. Whether inhaled NO was administered or not in the surgical ICU, a significant relationship was found between indoor and outdoor concentrations of NO, suggesting that NO concentrations measured inside the ICU were predominantly influenced by outdoor air pollution (Figure 2).
|
|
As shown in Figure 3, an exponential relationship was found between indoor NO concentrations and atmospheric pressure. As shown in Figure 4, a significant decrease in outdoor NO concentration was observed during windy periods. Similarly, the presence of cloudy weather was associated with lower concentrations of NO: 159 ± 140 ppb during periods with cloud mass > 40% versus 273 ± 166 ppb during periods with cloud mass < 40%, p < 0.01. Ambient concentrations of NO measured along the circular highway of Paris at rush hour and in the presence of backed-up traffic are shown in Table 1. Although very similar conditions of automobile traffic were observed during the 3 d when measurements were performed, NO and NO2 concentrations appeared markedly influenced by climatic conditions.
|
|
|
The stepwise logistic regression analysis identified elevated outdoor NO2 concentrations as an independent factor associated with an increase in indoor NO2 concentrations. As shown in Figure 5, outdoor NO2 concentrations (NO2OUT) significantly increased when atmospheric pressures above 1,020 mbar were observed. Outdoor NO2 concentrations significantly decreased in the presence of cloudy and windy weather and were not dependent on outdoor NO concentrations. As shown in Table 1, concentrations of NO2 measured along the circular highway of Paris nearly reached 1 ppm on July 20, 1995.
|
| |
DISCUSSION |
|---|
|
|
|---|
In a Parisian intensive care unit where critically ill patients with acute respiratory failure are routinely treated with inhaled NO, we found that indoor NO and NO2 concentrations were mainly influenced by outdoor pollution and did not increase with therapeutic NO administration. Elevated indoor NO and NO2 concentrations were almost always associated with climatic factors such as high atmospheric pressure, absence of wind, and clear sky and never with administration of NO to one or several patients in the ICU.
Before extending these results to all critical care units,
some specific characteristics of the ICU where the study was
performed should be outlined: First, its geographic situation
within the extended urban area of Paris characterized by a
population of around 12 million inhabitants, a dense industrial
network, heavy and quasi-continuous automobile traffic, and
therefore, a high level of outdoor pollution. In this context,
NO administered by the inhalation route to mechanically ventilated patients did not appear to be a significant additional
exogenous source of NO and NO2 adding to nitrogen oxides
produced by industry, gasoline engines, and domestic devices
such a gas stoves, kerosene-fueled space heaters, cooking
ranges, and pilot lights (15). Second, the data were obtained in
an ICU where several prospective studies on NO dose response clearly demonstrated that the minimum inspiratory NO
concentration required for improving gas exchange in critically ill adult patients is generally less than 5 ppm (5, 12, 13). Therefore, NO was administered at inspiratory concentration
5 ppm in contrast to many ICUs where, during the same period, higher doses ranging between 10 and 40 ppm were routinely administered. If exhaled NO coming out from the ventilator is a significant source of indoor NO pollution, then the
expired concentration should play a determinant role. In patients with acute respiratory failure, pulmonary absorption of
NO is reduced because the alveolar surface available for gas
exchange is markedly decreased. In healthy humans, expired
NO represents 2-30% of the inspired concentration, whereas
in patients with ARF, expired NO represents 40-60% of the
inspired concentration (13). In our surgical ICU with the same
system of administration, NO concentrations of 2.8, 6.8, and
17 ppm were found in expired gases of patients with acute respiratory failure receiving inspiratory NO concentrations of 4.5, 15, and 45 ppm, respectively (13). Our results may not apply to ICUs where higher concentrations of NO are routinely administered (3, 7, 8, 16, 17) and/or located far away from urban polluted areas. The mode of NO administration may also
influence contamination of the ambient atmosphere of the
ICU. Continuous administration of NO during the entire respiratory cycle is likely to produce more contamination of the
environment than sequential administration limited to the inspiratory phase. In pediatric ICUs, where pressure generator
ventilators based on continuous high flow sweeping the respiratory tubings are used, the NO concentration of the exhaust
gas is very close to the inspiratory concentration. Because
higher doses of NO are used in infants and neonates (16, 17),
the contamination of the ambient atmosphere of the ICU may
be significant. Only studies measuring indoor concentrations of NO and NO2 in the presence or absence of NO administration in pediatric ICUs will indicate whether medical and paramedical teams are exposed to higher ambient concentrations
of NO and NO2. In an adult unit, we never found indoor NO
and NO2 concentrations exceeding 0.7 ppm, which is far away
from the accepted limit for NO and NO2 exposures in the
workplace, i.e., 25 ppm over an 8-h period (18). On July 20, 1995 we measured outdoor NO and NO2 concentrations of 1.7 and 0.995 ppm, respectively, along the circular highway of
Paris in the presence of backed-up traffic. In the ICU, corresponding indoor concentrations of NO and NO2 were found at
0.652 and 0.22 ppm, respectively.
Inhabitants of big cities continuously inhale small quantities of NO and NO2 issued from outdoor and domestic pollution. Therapeutic administration of NO does not appear to be
a significant additional source of nitrogen oxides. Clear and
sunny weather characterized by high atmospheric pressure,
heavy automobile traffic, and lack of wind movement are generally associated with the highest outdoor and indoor NO concentrations. In an ICU where therapeutic NO concentrations
5 ppm are used, protection of nurses and medical staff
against incidental inhalation of nitrogen oxides should start
with general attempts at reducing urban pollution rather than
with specific scavenging of NO coming out from the ventilators.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Pr. J. J. Rouby, Unité de Réanimation Chirurgicale, Département d'Anesthésie-Réanimation, Hôpital de la Pitié-Salpétrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.
(Received in original form December 2, 1996 and in revised form March 14, 1997).
| |
References |
|---|
|
|
|---|
1. Devalia, J. L., C. Rusznak, and R. J. Davies. 1994. Air pollution in the 1990s: cause of increased respiratory disease? Respir. Med. 88: 241-244 [Medline].
2. Alberts, W. M.. 1994. Indoor air pollution: NO, NO2, CO and CO2. J. Allergy Clin. Immunol. 94: 289-295 [Medline].
3.
Rossaint, R.,
K. J. Falke,
F. Lopez,
K. Slama,
U. Pison, and
W. M. Zapol.
1993.
Inhaled nitric oxide for the adult respiratory distress syndrome.
N. Engl. J. Med.
328:
399-405
4. Gerlach, H., R. Rossaint, D. Pappert, and K. J. Falke. 1993. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur. J. Clin. Invest. 23: 499-502 [Medline].
5. Puybasset, L., J. J. Rouby, E. Mourgeon, T. E. Stewart, P. Cluzel, M. F. Belin, P. Grenier, M. Arthaud, P. Poète, L. Bodin, A. M. Korinek, and P. Viars. 1994. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med. 20: 319-327 [Medline].
6. Puybasset, L., T. Stewart, J. J. Rouby, P. Cluzel, E. Mourgeon, M. F. Belin, M. Arthaud, C. Landaut, and P. Viars. 1994. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with adult respiratory distress syndrome. Anesthesiology 80: 1254-1267 [Medline].
7. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, and W. M. Zapol. 1994. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80: 761-770 [Medline].
8.
Young, J. D.,
W. J. Brampton,
J. D. Knighton, and
S. R. Finfer.
1994.
Inhaled nitric oxide in acute respiratory failure in adults.
Br. J. Anaesth.
73:
499-502
9. Puybasset, L., J. J. Rouby, E. Mourgeon, P. Cluzel, J. D. Law-Koune, T. E. Stewart, C. Devilliers, Q. Lu, S. Roche, P. Kalfon, E. Vicaut, and P. Viars. 1995. Inhaled NO in acute respiratory failure: factors influencing pulmonary vascular effects and arterial oxygenation. Am. J. Respir. Crit. Care Med. 152: 318-328 [Abstract].
10. Wessel, D. L., I. Adlatia, J. E. Thompson, and P. R. Hickey. 1994. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit. Care Med. 22: 930-938 [Medline].
11. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. LeGall, A. Morris, R. Spragg, and the Consensus Committee. 1994. Report of the American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med. 20: 225-232 [Medline].
12. Mourgeon, E., L. Puybosset, J. D. Law-Koune, Q. Lu, L. Abdenour, L. Gallart, P. Malassine, G. S. Umamaheswara Rao, P. Cluzel, A. Bennani, P. Coriat, and J. J. Rouby. 1997. Inhaled nitric oxide in acute respiratory distress with and without septic shock requiring norepinephrine administration: a dose response study. Critical Care (In press)
13. Lu, Q., E. Mourgeon, J. D. Law-Koune, S. Roche, C. Vézinet, L. Abdenour, E. Vicaut, L. Puybasset, M. Diaby, P. Coriat, and J. J. Rouby. 1995. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide responding patients with acute respiratory distress syndrome. Anesthesiology 83: 929-943 [Medline].
14. Wysocki, M., C. Delcaux, E. Roupie, D. Langeron, N. Liu, B. Herman, F. Lemaire, and L. Brochard. 1994. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bimesylate in the adult respiratory distress syndrome. Intensive Care Med. 20: 254-259 [Medline].
15. Alberts, W. M.. 1994. Indoor air pollution: NO, NO2, CO, and CO2. J. Allergy Clin. Immunol. 94: 289-295 .
16.
Roberts, J. D.,
P. Lang,
L. M. Bigatello,
G. J. Vlahakes, and
W. M. Zapol.
1993.
Inhaled nitric oxide in congenital heart disease.
Circulation
87:
447-453
17. Muller, W., W. Kachel, P. Lasch, V. Varnholt, and S. A. Koing. 1996. Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn. Intensive Care Med. 22: 71-76 [Medline].
18. Centers for Disease Control. 1988. Recommendations for occupational safety and health standard. MMWR COC Surveill. Summ. 37(Suppl.): 21 .
This article has been cited by other articles:
![]() |
M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF] |
||||
![]() |
M. A. Qureshi, N. J. Shah, C. W. Hemmen, M. C. Thill, and J. A. Kruse Exposure of Intensive Care Unit Nurses to Nitric Oxide and Nitrogen Dioxide During Therapeutic Use of Inhaled Nitric Oxide in Adults With Acute Respiratory Distress Syndrome Am. J. Crit. Care., March 1, 2003; 12(2): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bushman Essentials of Nitric Oxide for the Pediatric (Cardiac) Anesthesiologist Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 79 - 90. [Abstract] [PDF] |
||||
![]() |
C. S Hayward, R. P Kelly, and P. S Macdonald Inhaled nitric oxide in cardiology practice Cardiovasc Res, August 15, 1999; 43(3): 628 - 638. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |